TABLE 1.
Source of strain or MIC parametera | Strain | MBL productionb | MIC (μg/ml) of β-lactamc: |
|||||
---|---|---|---|---|---|---|---|---|
IMP | MEM | PIP | AZT | CTX | CAZ | |||
CU | MCC04446 | 46.0 | 0.75 | 3 | 1.5 | 6 | 6 | 6 |
CU | MCC04511 | 28.7 | >32 | >32 | 4 | 6 | 4 | 2 |
CU | MCC04517 | 37.8 | 3 | 6 | 3 | 4 | 2 | 6 |
CSOM | MCC09159 | 44.7 | 2 | −12 | 0.75 | 2 | 1.5 | 4 |
AOE | MCC10330T | 42.3 | 3 | 3 | 4 | 4 | 2 | 6 |
AOE | MCC10429 | 58.1 | 2 | 2 | 6 | 4 | 6 | 8 |
AOE | MCC10744 | 66.7 | 1 | 2 | 4 | 6 | 4 | 3 |
AOE | MCC11140 | 42.4 | 1.5 | 1 | 4 | 6 | 3 | 6 |
AOE | MCC11061 | 28.5 | 1 | 2 | 4 | 8 | 3 | 4 |
AOE | MCC11338 | 41.1 | 1 | 3 | 1.5 | 2 | 2 | 4 |
AOE | MCC11683 | 30.3 | 1 | 1.5 | 0.75 | 6 | 4 | 4 |
AOE | MCC12065 | 38.8 | 0.5 | 4 | 1.5 | 6 | 2 | 4 |
AOE | MCC12178 | 36.2 | 1.5 | 2 | 4 | 8 | 3 | 3 |
AOM | MCC40150 | 17.9 | 1 | 2 | 1.5 | 3 | 1.5 | 3 |
AOM | MCC40159 | 16.6 | 0.75 | 6 | 4 | 8 | 4 | 3 |
AOM | MCC51196 | 15.1 | 0.75 | 0.25 | 1 | 6 | 3 | 3 |
AOMT | MCC61379 | 97.2 | 2 | 16 | 3 | 6 | 4 | 4 |
AOMT | MCC61485 | 16.1 | 2 | 2 | 2 | 6 | 2 | 3 |
AOMT | MCC61433 | 31.5 | 2 | 24 | 3 | 4 | 4 | 4 |
CSOM | YMC-Po/06 | 81.7 | >32 | >32 | 2 | 4 | 3 | 4 |
MIC range | 0.50->32 | 0.25->32 | 0.75-6 | 2-8 | 1.5-6 | 2-8 | ||
MIC50 | 1.5 | 3 | 3 | 6 | 3 | 4 | ||
MIC90 | 3 | 24 | 4 | 8 | 4 | 6 |
CU, corneal ulcer; CSOM, chronic suppurative otitis media; AOE, acute otitis externa; AOM, acute otitis media; AOMT, otitis media with otorrhoea drainage through tympanostomy tube.
MBL production is shown in nanomoles of imipenem hydrolyzed per minute per milligram of protein. Data are the mean values of measurements for three replicate samples (the standard deviation was always <10%); in all cases, the activity was inhibited by at least 80% in the presence of EDTA. Carbapenemase activity measured with the negative control (P. aeruginosa ATCC 27853) yielded a value of <10 nmol of imipenem hydrolyzed/min/mg of protein.
The MICs were determined by Etest. IMP, imipenem; MEM, meropenem; PIP, piperacillin; AZT, aztreonam; CTX, cefotaxime; CAZ, ceftazidime.